Cost-effectiveness of Ivabradine as a Treatment for Systolic Chronic Heart Failure in the United States

被引：0
|
作者：
Kansal, Anuraag R.
Cowie, Martin
Kielhorn, Adrian
Krotneva, Stanimira
Taffazzoli, Ali
Zheng, Ying
Yurgin, Nicole
机构：
来源：
CIRCULATION | 2015年 / 132卷
关键词：
cost effectiveness; systolic chronic heart failure; ivabradine; quality-adjusted life years; hospitalization;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
17655
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Cost-Effectiveness of long-term tolvaptan administration for chronic heart failure treatment in Japan
    Nakao, Yasuhisa
    Kawakami, Hiroshi
    Saito, Makoto
    Inoue, Katsuji
    Ikeda, Shuntaro
    Yamaguchi, Osamu
    JOURNAL OF CARDIOLOGY, 2022, 79 (03) : 408 - 416
  • [22] COST-EFFECTIVENESS OF PNEUMOCOCCAL VACCINATION AMONG PATIENTS WITH CHRONIC HEART FAILURE
    Rudakova, A., V
    Briko, N., I
    Lobzin, Yu, V
    Namazova-Baranova, L. S.
    Avdeev, S. N.
    Kostinov, M. P.
    Korshunov, V. A.
    Fomin, I., V
    KARDIOLOGIYA, 2023, 63 (05) : 19 - 26
  • [23] Real-life indications to ivabradine treatment for heart rate optimization in patients with chronic systolic heart failure
    Tondi, Lara
    Fragasso, Gabriele
    Spoladore, Roberto
    Pinto, Giuseppe
    Gemma, Marco
    Slavich, Massimo
    Godino, Cosmo
    Salerno, Anna
    Montanaro, Claudia
    Margonato, Alberto
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2018, 19 (07) : 351 - 356
  • [24] Modelling the cost-effectiveness of tofacitinib for the treatment of rheumatoid arthritis in the United States
    Claxton, Lindsay
    Taylor, Matthew
    Gerber, Robert A.
    Gruben, David
    Moynagh, Dermot
    Singh, Amitabh
    Wallenstein, Gene, V
    CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (11) : 1991 - 2000
  • [25] Cost-effectiveness of sacubitril/valsartan in chronic heart-failure patients with reduced ejection fraction
    Zanfina, Ademi
    Alena, Pfeil Ma
    Elizabeth, Hancock
    David, Trueman
    Rola, Haroun
    Celine, Deschaseaux
    Matthias, Schwenkglenks
    SWISS MEDICAL WEEKLY, 2017, 147
  • [26] COST-EFFECTIVENESS OF TELEHEALTH INTERVENTIONS FOR CHRONIC HEART FAILURE PATIENTS: A LITERATURE REVIEW
    Grustam, Andrija S.
    Severens, Johan L.
    van Nijnatten, Jan
    Koymans, Ron
    Vrijhoef, Hubertus J. M.
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2014, 30 (01) : 59 - 68
  • [27] Cost-Effectiveness of Implantable Pulmonary Artery Pressure Monitoring in Chronic Heart Failure
    Sandhu, Alexander T.
    Goldhaber-Fiebert, Jeremy D.
    Owens, Douglas K.
    Turakhia, Mintu P.
    Kaiser, Daniel W.
    Heidenreich, Paul A.
    JACC-HEART FAILURE, 2016, 4 (05) : 368 - 375
  • [28] Cost-effectiveness analysis of nivolumab for the treatment of squamous cell carcinoma of the head and neck in the United States
    Haddad, Robert
    Cohen, Ezra E. W.
    Venkatachalam, Meena
    Young, Kate
    Singh, Prianka
    Shaw, James W.
    Korytowsky, Beata
    Abraham, Pranav
    Harrington, Kevin J.
    JOURNAL OF MEDICAL ECONOMICS, 2020, 23 (05) : 442 - 447
  • [29] The cost-effectiveness of temozolomide in the adjuvant treatment of newly diagnosed glioblastoma in the United States
    Messali, Andrew
    Hay, Joel W.
    Villacorta, Reginald
    NEURO-ONCOLOGY, 2013, 15 (11) : 1532 - 1542
  • [30] Cost-effectiveness of tildrakizumab for the treatment of moderate-to-severe psoriasis in the United States
    Jia, Xiaoying
    Zhao, Yang
    Carrico, Justin
    Brodtkorb, Thor-Henrik
    Mendelsohn, Alan M.
    Lowry, Simon
    Feldman, Steve
    Wu, Jashin J.
    Armstrong, April W.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (02) : 740 - 748
12345